Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronutrient, fatty acid, and bone health assessment in patients with phenylketonuria
NL-OMON38467Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2013
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sapropterin in phenylketonuria (PKU), sponsored by Amsterdam University Medical Center. Primary endpoints: Prescribed micronutrient and fatty acid intake and Correlation of prescribed intake with blood levels. Started May 2013; status: active, not recruiting.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NL-OMON38467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38467.